175 related articles for article (PubMed ID: 30271932)
21. Spatial and Cellular Expression Patterns of Erythropoietin-Receptor and Erythropoietin during a 42-Day Post-Lesional Time Course after Graded Thoracic Spinal Cord Impact Lesions in the Rat.
Cohrs G; Goerden S; Lucius R; Synowitz M; Mehdorn HM; Held-Feindt J; Knerlich-Lukoschus F
J Neurotrauma; 2018 Feb; 35(3):593-607. PubMed ID: 28895456
[TBL] [Abstract][Full Text] [Related]
22. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
23. Expression of erythropoietin and its receptor in neuroblastomas.
Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction.
Okonko DO; Marley SB; Anker SD; Poole-Wilson PA; Gordon MY
Int J Cardiol; 2013 Apr; 164(3):359-64. PubMed ID: 21821297
[TBL] [Abstract][Full Text] [Related]
25. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
26. A critical role for erythropoietin on vagus nerve Schwann cells in intestinal motility.
Govindappa PK; Begom M; Gupta Y; Elfar JC; Rawat M; Elfar W
BMC Biotechnol; 2023 May; 23(1):12. PubMed ID: 37127673
[TBL] [Abstract][Full Text] [Related]
27. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
Gombos Z; Danihel L; Repiska V; Acs G; Furth E
Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
[TBL] [Abstract][Full Text] [Related]
28. Chorioamnionitis disrupts erythropoietin and melatonin homeostasis through the placental-fetal-brain axis during critical developmental periods.
Kitase Y; Madurai NK; Hamimi S; Hellinger RL; Odukoya OA; Ramachandra S; Muthukumar S; Vasan V; Sevensky R; Kirk SE; Gall A; Heck T; Ozen M; Orsburn BC; Robinson S; Jantzie LL
Front Physiol; 2023; 14():1201699. PubMed ID: 37546540
[No Abstract] [Full Text] [Related]
29. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the Asymmetry of Activated EPO Receptor Enables Designing Small Molecule Agonists.
Guarnieri F
Vitam Horm; 2017; 105():19-37. PubMed ID: 28629518
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma.
Wang L; Li HG; Xia ZS; Wen JM; Lv J
World J Gastroenterol; 2011 Sep; 17(34):3933-40. PubMed ID: 22025882
[TBL] [Abstract][Full Text] [Related]
32. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
33. Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.
Wei M; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2007; 39(3):935-40. PubMed ID: 17534732
[TBL] [Abstract][Full Text] [Related]
34. [EPO and EPOR Expression in Patients with Acute Leukemia and Its Clinical Significance].
Tian RM; Huang CS; Su Q; Shi L; Luo X; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1026-1032. PubMed ID: 31418352
[TBL] [Abstract][Full Text] [Related]
35. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
[TBL] [Abstract][Full Text] [Related]
36. Characterization of three erythropoietin (Epo)-binding proteins in various human Epo-responsive cell lines and in cells transfected with human Epo-receptor cDNA.
Takahashi T; Chiba S; Hirano N; Yazaki Y; Hirai H
Blood; 1995 Jan; 85(1):106-14. PubMed ID: 7803787
[TBL] [Abstract][Full Text] [Related]
37. Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.
Bulut GB; Sulahian R; Yao H; Huang LJ
Blood; 2013 Dec; 122(24):3964-72. PubMed ID: 24113870
[TBL] [Abstract][Full Text] [Related]
38. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.
Sokol L; Luhovy M; Guan Y; Prchal JF; Semenza GL; Prchal JT
Blood; 1995 Jul; 86(1):15-22. PubMed ID: 7795221
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
Chan KK; Matchett KB; Coulter JA; Yuen HF; McCrudden CM; Zhang SD; Irwin GW; Davidson MA; Rülicke T; Schober S; Hengst L; Jaekel H; Platt-Higgins A; Rudland PS; Mills KI; Maxwell P; El-Tanani M; Lappin TR
Oncotarget; 2017 Jun; 8(24):38251-38263. PubMed ID: 28418910
[TBL] [Abstract][Full Text] [Related]
40. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.
Singh S; Dev A; Verma R; Pradeep A; Sathyanarayana P; Green JM; Narayanan A; Wojchowski DM
PLoS One; 2012; 7(7):e38530. PubMed ID: 22808010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]